Randomised controlled trialindependent cross-checkabstract only checked★ key study I-SOD-03 in-depth review

Sweeteners and blood sugar: a 120-person trial

Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance.

Overview

Suez J et al.. Cell 2022 · PMID 35987213 · DOI 10.1016/j.cell.2022.07.016

Saccharin and sucralose worsened glucose responses in some people; aspartame and stevia did not significantly.

Does the study support the specific claim? Partly · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Do NNS causally affect human microbiome and glycaemic responses?

How was the study done?

Randomized controlled trial (2 weeks) plus gnotobiotic mouse transfer.

How many people, animals or samples were studied?

120; Healthy adults

What was actually found?

Each NNS distinctly altered stool and oral microbiome and plasma metabolome; saccharin and sucralose significantly impaired glycaemic responses; responder-specific effects reproduced in mice.

How large was the observed effect?

Qualitative (numbers not in abstract)

What do the results mean in everyday life?

Some sweeteners affect some people.

What are the study's limitations?

Short (2 weeks); Clinical relevance unknown; Authors' commercial interests

What does it say about Elawady's specific claim?

Mixed for C-SOD-07.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Long-term disease risk.

Scientific in-depth review

1. Full reference

Authors
Suez J et al.
Journal
Cell
Year
2022
Identifier
PMID 35987213 DOI 10.1016/j.cell.2022.07.016
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Some authors co-founders of DayTwo/BiomX

2. Research question

Do NNS causally affect human microbiome and glycaemic responses?

3. Study design and population

Study design
Randomised controlled trial – Randomized controlled trial (2 weeks) plus gnotobiotic mouse transfer.
Population

Healthy adults

Country

Israel

Period

not stated in abstract

Sample size

120

Inclusion and exclusion criteria

not stated in abstract

4. Methods and endpoints

Exposure / intervention

Saccharin, sucralose, aspartame, stevia sachets below ADI

Comparator

Glucose vehicle or no supplement

Endpoints

Microbiome, metabolome, glycaemic responses

Statistical methods

Group comparisons; mouse transfer

5. Actual results

Results

Each NNS distinctly altered stool and oral microbiome and plasma metabolome; saccharin and sucralose significantly impaired glycaemic responses; responder-specific effects reproduced in mice.

Absolute risks

not applicable

Authors' conclusion

NNS may induce person-specific, microbiome-dependent glycaemic alterations.

6. Strengths

  • Randomized
  • Causal mouse transfer

7. Weaknesses

  • Short (2 weeks)
  • Clinical relevance unknown
  • Authors' commercial interests

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Industry ties; multiple comparisons.

9. Assessment of the statistical interpretation

Effects sweetener-specific.

10. Relevance to the specific claim

Mixed for C-SOD-07.

11. Independent contrary findings

Aspartame and stevia without significant glycaemic impairment.

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Best human evidence on NNS and microbiome.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Long-term effects.

15. Linked fact checks